Development and evaluation of a pharmaceutical care program to reduce modifiable risk of chronic complications in brazilian type 2 diabetic patients
In this study we developed and evaluated a pharmaceutical care program (PCP) to reduce modifiable risk factors of chronic complications of type 2 diabetes. Patients who acquired their anti-diabetic drugs from a Brazilian community pharmacies chain were invited to participate in the PCP. The recrui...
Guardado en:
| Autores principales: | Silva, Gisleine E. C. da, Bazotte, Roberto B. |
|---|---|
| Formato: | Articulo |
| Lenguaje: | Inglés |
| Publicado: |
2011
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/8115 http://www.latamjpharm.org/resumenes/30/1/LAJOP_30_1_1_23.pdf |
| Aporte de: |
Ejemplares similares
-
Hypovitaminosis D in patients with type 2 diabetes : risk factors and association with glycemic control and established microvascular complications
por: Ramírez Stieben, Luis Agustín, et al.
Publicado: (2022) -
Frequency and associated risk factors of cardiovascular autonomic neuropathy among patients with type 2 Diabetes
por: Romero, Silvana A., et al.
Publicado: (2018) -
How to implement pharmaceutical care in the curriculum? : The Cuban pharmacy education experiences
por: Martínez Sánchez, Alina M.
Publicado: (2009) -
Diabetic patients without health coverage: drug use, adherence and complications arising from their underlying disease
por: Brusa, Andrea Fabiana, et al.
Publicado: (2014) -
Diabetes Care /
Publicado: (1978)